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A B S T R A C T
The morphology of gastrocnemius muscles was examined in RFPs (renal failure patients) being
treated using HD (haemodialysis) and CAPD (continuous ambulatory peritoneal dialysis). RFPs
(n= 24) volunteered to participate in the present study. Twelve RFPs (five women and seven
men; mean age, 55 years) were undergoing CAPD treatment and 12 RFPs (two women and
ten men; mean age, 62 years) were undergoing HD treatment. Muscle biopsies from gastro-
cnemius muscles were found not to differ (P> 0.05) in fibre type distribution, MyHC (myosin heavy
chain) expression or fibre CSA (cross-sectional area) between the two groups. There were,
however, significant differences (P< 0.05) in CC/F (capillary contact/fibre), C/F (capillary to
fibre ratio) and cytochrome c oxidase activity. The HD group had 33 % more CC/F, with a
19 % higher C/F and 33 % greater cytochrome c activity in glycolytic fibres (II) than the CAPD
group. There were no apparent differences in age, gender, co-morbidity, self-reported physical
activity or physical functioning between the two groups, which could account for the difference in
muscle capillarity between the groups. The HD patients were, however, administered heparin as
a routine part of the dialysis therapy. The possibility is discussed that heparin in combination with
mild anaemia and acidosis may have augmented angiogenesis in the HD patients.
INTRODUCTION
Renal failure may be treated with HD (haemodialysis),
peritoneal dialysis and renal transplantation. The most
common treatmentmodalities areHD andCAPD (conti-
nuous ambulatory peritoneal dialysis), but they differ in
terms of technique and function [1]. However, studies
examining the effect of dialysis treatment modality on
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several biochemical factors have shown that HD and
CAPDhave a similar effect on overall mortality andmor-
bidity levels, particularly when co-morbid illness and
acuity of onset of renal failure are taken into consideration
[1].
One of the differences between the two dialysis modes
is the fluctuation of toxins in the body. CAPD patients
maintain a more constant level of uraemic toxins (dialysis
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every 4 h), whereas HD patients go from very low levels
on post-dialysis to very high ones at pre-dialysis (three
times a week). Moreover, CAPD treatment provides pa-
tients with more freedom and independent lifestyle than
HD, which requires patients to spend at least 12 h a week
on a dialysis unit.
Itwould seem logical therefore to assume that, as a con-
sequence of the greater opportunity for physical activity,
CAPD patients would have a better preserved exercise
capacity andmusclemorphology.However, previous stu-
dies havebeenunable to showdifferences betweenCAPD
and HD patients in the performance of exercise tests [2].
In these studies, no measurements were made of muscle
morphology, although it is well known that chronic and
end-stageRFPs (renal failure patients) suffer frommuscu-
lar atrophy and myopathy-neuropathy symptoms
[3–6].
Therefore the aim of the present study was to exa-
mine the morphometric and morphological characteri-
stics of the gastrocnemius muscle of RFPs undergoing
CAPD and HD treatments. We hypothesized that, due
to the differences in treatment for renal failure, those
patients receiving HD would have smaller muscle fibres
and a reducedmuscle capillarization comparedwith those
patients receivingCAPD,due to the constraints described
previously.
METHODS
Patient characteristics and dialysis
regimens
Patients (n= 24) with end-stage renal disease participated
in the present study. Twelve patients [five women and
seven men; mean (range) age, 55 (37–70) years, and mean
(range) mass, 79 (51–105) kg] were recruited from the
CAPD unit and 12 patients [two women and ten men;
mean (range) age, 62 (35–76) years, and mean (range)
mass, 75 (60–90) kg] were recruited from the HD unit.
The patients had required regular dialysis treatment
on average for 47 months (range, 7–196 months) for the
CAPD group and 47 months (range, 6–192 months) for
the HD group.
The CAPD patients received, during the day, 4×
2-litre exchanges with a 1.36 or 3.86% glucose concen-
tration. The dialysis prescription is based on either 3×
1.36% plus 1× 3.86% (3:1 regimen) or 2× 1.36% plus
2× 3.86% (2:2 regimen). The peritoneal dialysis fluid
consisted of 5.38 g/l NaCl, 4.48 g/l sodium lactate,
0.184 g/l CaCl2 and 0.051 g/l MgCl2.
HD was performed three times/week for 4 h per se-
ssion, using standard dialysates containing 2.0 g/l glucose
and a 1.8 m2 dialyser. The blood flow rate was stan-
dardized at 300 ml/min, and the dialysate flow rate
standardized at 500 ml/min.
Table 1 Physical characteristics and co-morbidity of the
study population
Group Gender Age (years) Co-morbidity
CAPD patients
1 Male 59 Peripheral vascular disease (1)
2 Female 65 None (0)
3 Male 61 Ischaemic heart disease (1)
4 Male 50 Insulin-dependent diabetes mellitus (1)
5 Female 40 None (0)
6 Male 70 Ischaemic heart disease and left
ventricular dysfunction (2)
7 Female 55 None (0)
8 Male 63 Peripheral vascular disease, insulin-
dependent diabetes mellitus and
asthma (3)
9 Male 44 Asthma (1)
10 Female 67 Insulin-dependent diabetes mellitus (1)
11 Male 37 Asthma (1)
12 Female 51 None (0)
HD patients
1 Male 74 Ischaemic heart disease (1)
2 Female 76 Ischaemic heart disease and peripheral
vascular disease (2)
3 Female 69 Peripheral vascular disease (1)
4 Male 53 None (0)
5 Male 74 Peripheral vascular disease (1)
6 Male 48 None (0)
7 Male 44 Left ventricular dysfunction (1)
8 Male 55 None (0)
9 Male 71 Ischaemic heart disease (1)
10 Male 35 Asthma (1)
11 Male 70 None (0)
12 Male 71 Arthritis (1)
None of the RFPs had used any corticosteroids or
other drug known to induce muscle catabolism at the
time of biopsy. The co-morbidity level of the RFPs was
0.7 (range, 0–3) and 0.8 (range, 0–2) for the CAPD and
HD patients respectively (Table 1).
Seven patients from the CAPD group and nine
patients from the HD group were treated with r-HuEPO
[recombinant human erythropoietin; 5000+− 1700 IU
(international units)/week for CAPD and 6000+−
2300 IU/week for HD; EPREX; Janssen-cilag]. All of the
HD patients were treated with heparin (3000+− 1200 IU)
during HD in order to prevent blood clotting. Seven
patients from the CAPD group and three patients from
the HD group were treated with β-adrenergic blockers.
All of the patients were given both an oral and written
explanation of the purpose and procedures of the study
prior to participation and provided written informed
consent. All procedures were approved by the North
Staffordshire Hospital Medical Ethics Committee.
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Muscle biopsy
A muscle biopsy (100–200 mg of wet tissue) for histo-
chemical and quantitative enzymic analysis was taken
from the medial head of the right gastrocnemius muscle
of eachRFP using the conchotome technique. The biopsy
specimen was kept moist on a piece of saline-moistened
gauze. The biopsy was cut into two parts at right angles
in relation to the direction of muscle fibres, one part was
used for histology/histochemistry analysis and the re-
mainder for gel electrophoretic determination of MyHC
(myosin heavy chain) composition.
Histological and histochemical study
The biopsy material was rapidly frozen in isopentane
(− 155 ◦C) for 10 s and stored in liquid nitrogen. Serial
sections of the samples were obtained by cutting trans-
verse sections of the biopsy (10 µm thickness in a cryo-
stat; Leica cm 1800) at − 25 ◦C and processed for histo-
logical staining.
The histochemical stains used were haematoxylin
and eosin, Harris’s haematoxylin [7] for morphological
examination, acid-labile myofibrillar ATPase [8] pre-
incubated at pH 4.40 and 4.75 to determine the percen-
tage of type I, IIa and IIx fibres, α-amylase-PAS (periodic
acid Schiff reagent) [9] for capillary density and the di-
aminobenzidinemethodforcytochromecoxidase activity
[10]. The morphometric analysis was semi-automatic and
performed with a camera (E.A.S.Y. 429K) connected to a
light-microscope (Zeiss axioskop) and digitizer (Mit-
subishi: Video Copy Processor, Herolab: molecular tech-
nique software) connected to a PC. The quantification
of the cytochrome c oxidase enzyme was performed
with IBAS system (IBAS 2.0, Kontron Electronik).
This quantification procedure has been described previ-
ously [11].
CSA (cross-sectional area) and circumference were
calculated from a minimum of 50 fibres from type I and
type IIa fibres and up to 50 fibres for type IIx, dependent
upon the availability of the type IIx fibres. The fibre type
distribution was determined from sections stained for
myofibrillar ATPase and approx. 250 fibres for each
sampleweremeasured.Morphometric analysis of the bio-
psywas performedwithout prior knowledge of the group
origin.
Atrophy threshold
In the absence of comparable control data, we classified
as atrophic all those fibres with a CSA below a cut-off
criterion of 2× S.D. of the mean CSA for the given
fibre type and subject. This was essentially based on the
atrophy factor calculations proposed by Brook and Engel
[12]. According to Brook and Engel [12], the S.D. of a
healthy individual’s mean fibre CSA is always 0.25 of
themeanCSA for a given fibre type.Moreover, according
to the same authors, the further fibres lie on the edges of
the fibre size frequency distribution histogram the more
important they are in order to calculate the atrophy level.
Thereforewedecided that 2× S.D.would provide uswith
an appropriate range that safely excluded what can be
considered normal size fibres, but included the atrophic
‘outer-range’ distribution fibres.
Capillary profile
Capillaries were quantified manually from photographs
taken from the previously described image analysis sys-
tem. An area containing at least 150 fibres in each section
was selected for the capillary counting. Analysis of
capillary profiles included C/F (capillary/fibre ratio),
CD/mm2 (capillary density/mm2 ofmuscle tissue), CC/F
(capillary contact/fibre), DD (diffusion distance) and
ICD (intercapillary distance). All the above analyses were
derived from direct measurements. DD was calculated
from the mean fibre diameter divided by two. The ICD
was calculated from themean fibre circumference divided
by themeanCC/F for each patient. All the capillarymea-
surements were determined from 100 fibres, except the
CD/mm2, which included all the fibres within a specified
area (1 mm2). All transversely cut capillaries were coun-
ted and, if a capillary was sectioned longitudinally, it was
counted as one each time it crossed a junction between
three or more muscle fibres [9].
MyHC analysis
The proportion of MyHC isoforms present in the whole
muscle sample was determined as follows. Muscle speci-
mens (30–50 mg) were homogenized {1 mg of tissue/
10 µl of buffer solution [10% glycerol (w/v), 5% (w/v)
2-mercaptoethanol, 2.3% (w/v) SDS, 62.5 mMTris/HCl
(pH 6.8) and 0.001% (w/v) Bromophenol Blue]} and
incubated at 80 ◦C for 10 min. Samples were then
centrifuged at 12 000 g for 5 min at 4 ◦C. The supernatant
fractions were collected and stored separately (− 80 ◦C)
and analysed later by SDS/PAGE.
Vertical PAGE (0.75 mm thickness gels) in the pre-
sence of SDS was performed according to the methods
of Talmadge and Roy [13]. MyHC was analysed in high
glycerol-containing gels (30%, w/v). MyHC isoforms
from the gastrocnemius muscle were resolved into three
separate bands, MyHC I and IIa and IIx, in 8 and 2%
(w/v) polyacrylamide for separating and stacking gels
respectively. The percentage of acrylamide and bisac-
rylamide in the stock solution was 40:1. The gels were
run for approx. 22 h at a constant current of 20 mA and
at a temperature of 4 ◦C. The relative content of MyHC
isoformswas determinedbydensitometricmethods using
Coomassie-Blue-stained gels, and the protein bands were
identified according to their apparent molecular mass
compared with those of high-molecular-mass protein
markers (Sigma). The densitometric system used was
based on Herolab software as described above, and the
coefficient of variation of the gel analysis was 7.5%.
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Nutritional assessment
The nutritional status of the RFPs was assessed by the
SGA (subjective global assessment) method using a seven
point scale. The accuracy, reproducibility and validity of
these methods have been shown previously in dialysis
patients [14].
Functional capacity assessment
The daily activity level was determined by the ‘7-day
activity recall’ questionnaire administered by an exper-
ienced interviewer. This was based upon information
about the time spent performing three levels of activity,
including sleep time, during the previous 7 days [15]. All
patients on this study were sedentary upon entering the
study and did not engage in any regular physical activity.
Functional capacity was assessed using a variety of
objective measures, including (i) time to perform five sit-
to-stand-to-sit cycles (STS-5), (ii) number of sit-to-stand
cycles achieved in 60 s (STS-60), and (iii) a previously
validated corridor walking, stair climbing and descent
test (NSRI). The validity and short-term reliability of
this battery of tests has been established previously [16].
Blood variables
Blood samples were taken from HD patients on a non-
dialysis day and fromCAPDpatients 2 h after the change.
For both dialysis groups, blood was used for measure-
ment of urea creatinine mobilization, albumin concentra-
tion, mean venous tCO2 (total CO2), haemoglobin and
PTH (parathyroid hormone).
Statistical analysis
All analyses were carried out by using the statistical pack-
age SPSS 9.0 for Windows (SPSS, Chicago, IL, U.S.A.).
Standard descriptive statistics, consisting of mean and
S.D., were used to characterize the subject population.
A Mann–Whitney test was used to examine differences
in the variable effects between and within groups res-
pectively. The effect of length of dialysis treatments
were assessed as covariate factors in CSA and capillary
parameters. An α level ofP 0.05was selected to indicate
statistical significance.
RESULTS
Patients
The physical characteristics and co-morbidity of the
study population are shown in Table 1. There were no
differences in age and gender between the two groups
(P> 0.05). SGA indicated that three CAPD and two
HD patients were malnourished and were categorized
in B grade on the SGA scale, although no difference in
nutritional status was detectable between the groups
(P> 0.05). The HD group had a significantly lower
haemoglobin concentration (P< 0.05) and mean venous
Table 2 Clinical assessment of CAPD and HD patient
groups
Values are means+− S.D. ∗ P < 0.05 compared with HD patients. Kt/V ,
efficiency of the dialysis therapy.
Normal CAPD patients HD patients
range (n= 12) (n= 12)
Kt/V (Urea creatinine) < 1.5 2.5+− 1.3 1.5+− 0.3
Albumin concentration (g/dl) 35–50 39+− 5 39+− 4
Haemoglobin (g/dl) 13–18 12.6+− 1.3∗ 11.3+− 0.9
Mean venous tCO2 (mmol) 24–32 26+− 4∗ 22+− 2
PTH (pmol/l) 6–20 22+− 20 8.4+− 10
Table 3 Fibre type distribution and MyHC content
determined from histochemistry and SDS/PAGE
Values are mean+− S.D. No significant differences were observed between the two
groups.
CAPD patients (n= 12) HD patients (n= 12)
Fibre type
Type I (%) 59+− 12 60+− 18
Type IIa (%) 30+− 11 33+− 14
Type IIx (%) 11+− 10 7+− 7
MyHC content
MyHC I (%) 61+− 16 60+− 15
MyHC IIa (%) 23+− 10 24+− 13
MyHC IIx (%) 16+− 10 16+− 6
tCO2 (P< 0.01) than the CAPD group (Table 2). No
differences between groups were found with respect to
albumin or PTH concentration (P> 0.05).
Muscle fibre type composition: MyHC
isoform composition
In the present study, no differences were found between
the two groupswith regards to fibre type distribution and
MyHC isoform expression (Table 3).
Muscle fibre CSA
In the CAPD group, the mean CSA for type I fibres was
20 and 30% larger than type IIa and IIxfibres respectively
(Figure 1). In the HD group, there was no significant
difference between the mean CSA of the type I, IIa and
IIx fibres. Although themeanCSA for each fibre type and
for the combined weighted CSA for all fibre types was
smaller in the CAPD compared with HD group, none of
these differences was statistically significant (Figure 1).
Regarding the percentage of atrophic fibres found in the
two groups, no significant differences were observed
between the two groups (Table 4).
Capillary profile
CD/mm2 was not different between groups (290+− 110
compared with 300+− 77 CD/mm2 in the HD and
C© 2004 The Biochemical Society
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Figure 1 CSA of the different fibres types in CAPD (n= 12)
and HD (n= 12) patients
Values are means+− S.D. CSA, combined weighted CSA.
Table 4 Percentage of fibres classified as atrophic for the
CAPD and HD patient groups
Values are means+− S.D. No significant differences were found between the groups.
MCSA, mean CSA.
Atrophic fibres CAPD patients (n= 12) HD patients (n= 12)
Type I (%) 55+− 13 % 44+− 21 %
Type IIa (%) 63+− 9 % 47+− 25 %
Type IIx (%) 60+− 16 % 59+− 22 %
MCSA (%) 14+− 11 % 12+− 14 %
CAPD groups respectively). However, when expressed
in capillaries/fibre, the HD group had a 19% higher C/F
value than the CAPD group (1.9+− 0.4 compared with
1.6+− 0.2 respectively; P< 0.05). As a result, CC/F was
also higher in the HD group compared with the CAPD
group (4.1+− 0.6 compared with 3.1+− 0.6 respectively;
P< 0.01).
No statistical differences between the HD and CAPD
groups were found in measurements of the calculated
DDs (34+− 5 and 31+− 6 µm respectively). ICD was
70+− 16 and 81+− 21 µm in the HD and CAPD groups
respectively. In neither HD nor CAPD groups was there
a relationship between the mean fibre CSA and CC/F.
However, it should be noted that all of the values for the
HD group for CC/F independent of fibre CSA lie above
the regression line of CAPD (Figure 2).
Cytochrome c oxidase
The cytochrome c oxidase activity was higher in the type
II fibres of the HD (n= 11) compared with the
CAPD (n= 7) patients (0.20+− 0.04 comparedwith 0.15+−
0.02 IU respectively; P< 0.05). However, no difference
was seen in the cytochrome c oxidase activity in the
type II fibres between the two groups (0.30+− 0.05 IU
in the HD group compared with 0.30+− 0.06 IU in the
CAPD group).
Figure 2 Scatter plot and regression for individual data
points to show the distribution of CC/F and mean CSA in
CAPD (n= 12) and HD (n= 12) patients
Morphological features
The proportion of fibres with central located nuclei was
within the normal range ( 5%) for all groups. In the
CAPDgroup, the proportion of fibres with central nuclei
was 4.4+− 2.4% of the total fibre number, and in the HD
group it was 3.9+− 2.6%. These values were not signi-
ficantly different between the groups (P> 0.05).
Physical activity status
No differences were observed in daily activity level
between the two renal failure groups (2750+− 600 and
2750+− 610 kcal/day for the CAPD and HD groups
respectively; P> 0.05; where 1 kcal≡ 4.184 kJ). Similarly,
there were no differences detected in functional capacity
as assessed by STS-5 (13.1+− 3.8 compared with 13+− 3.5 s
for the CAPD and HD groups respectively), STS-60
(21.4+− 8 compared with 21.7+− 7 rep for the CAPD and
HD groups respectively; P> 0.05) or the walking test
(88+− 26 s compared with 85+− 17 s for the CAPD and
HD groups respectively; P> 0.05).
DISCUSSION
The present study set out to test the hypothesis that
muscle morphological indices of functional status would
be improved in patients receiving CAPD compared with
those receiving HD.
In contrast with the initial hypothesis, no difference
was found in muscle fibre type distribution or fibre size.
Even more surprisingly, and counterintuitively, loco-
motory muscle capillarization, as measured by C/F or
CC/F, was significantly greater in a group of RFPs being
treated with HD compared with those treated with
CAPD. Furthermore, the enhanced capillarization in the
HD group was also associated with a significantly higher
level of cytochrome c oxidase activity in type II fibres.
Both dialysis populations were similar in terms of
age, gender, physical activity, nutritional status and PTH
C© 2004 The Biochemical Society
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levels. However, the HD group had fewer females
compared with the CAPD group, and it is recognized
that gender may affect muscle fibre size such that young
males have been reported to have larger type I, IIa and
IIx muscle fibres (19, 59 and 66% larger respectively)
compared with young females (for example, see [17]). In
contrast with these findings for a younger population,
we found no significant difference in the weighted mean
CSA for all muscle fibres between our older males and
females. There were no statistically significant differences
in CSA between the CAPD and HD groups.
Renal failure has been shown to be associated with
atrophy of skeletal muscle, a condition commonly de-
scribed as uraemic myopathy [3–6]. In the present study,
we have compared the muscle morphology in HD and
CAPD patients. The fibre type percentage distribution
was similar between the two groups, with type I fibres
being the predominant fibre type. These data are in
agreement with other studies on gastrocnemius muscle
from RFPs [3] and healthy age-matched individuals [18].
In healthy subjects, it has often been observed that type II
fibres are slightly larger in CSA than type I fibres [19].
In the CAPD group, we found a reversal of this pattern,
with type II fibres being significantly smaller than type I
fibres by approx. 20–30%. It is possible that this repre-
sents an adaptation to the underlying pathology and may
be related to the inadequate nutrient supply consequent
upon a compromised microvasculature. It is interesting
that this apparent pathology-related ‘reversal’ of the
normal hierarchy of CSA was not seen in the HD group
(meanCSAvalues differingbyonly approx. 5–8%,which
was not statistically significant).
In our study, the HD group appeared more anaemic
and more metabolically acidotic than the CAPD group
(P< 0.05) (Table 2), and these could be two contributory
factors to explain the inter-group differences found
in capillarization (CC/F and C/F). Hypoxia has been
considered to be a stimulus to increase oxidative enzyme
activity (cytochrome c and succinate dehydrogenase) and
increase the concentration of aerobic enzymes found in
ischaemic muscles [20]. Our findings in the present study
from the analysis of cytochrome c oxidase showed that
type II glycolytic fibres of HD patients did indeed have
elevated enzyme activity levels, which were higher than
theCAPDgroup.Hudlicka et al. [21] suggested that long-
term hypoxia could be a stimulus for capillary growth
in both skeletal and cardiac muscles, where it could stim-
ulate the release of macrophage-derived growth factors.
Although, we do not have direct evidence of tissue hy-
poxia, it is possible that, due to chronic impairment in
blood oxygen carrying capacity, the RFPs could have
mimicked the characteristics of ischaemic muscles as a
consequence of anaemia. It is interesting to note that local
oxygen concentration regulatesVEGF (vascular endothe-
lial growth factor) expression and hypoxia appears to up-
regulate receptors for VEGF. VEGF is a potent stimulus
for angiogenesis and has been found to be elevated in the
ischaemic limb of rabbits and in ischaemic myocardium
[21]. Hudlicka et al. [21] have also proposed that a low
pH could trigger activation of endothelial cell growth
factors involved in capillary growth and angiogenesis.
Since the HD patients tended to be both acidotic and
anaemic (Table 2), these two factors in combination could
stimulate angiogenesis.
An unexpected, but major, finding was that the HD
group had 20–30% better capillarization, assessed in
terms of CC/F and C/F, compared with the CAPD
group. In assessing the measurements of capillarity, it is
important to remember that mitochondria are predom-
inantly located around the perimeter of the muscle fibre
and, hence, the distance between capillariesmaybe amore
discriminating measure of the structural competence of
the microvasculature rather than simple capillary density
when expressed as CD/mm2 CSA. Indeed, in the present
study, there was no difference in capillary density bet-
ween the CAPD and HD groups, despite the greater
number of capillaries per fibre and CC/F in the HD
group. This apparently anomalous result is the direct
consequence of the trend towards larger muscle fibres in
the HD group, thus diluting the degree of capillarization
when expressed inCD/mm2.Using the preferredmeasure
of ICD, which might reflect better the distance between
capillary and mitochondria around the perimeter of the
fibre, the calculated mean value is 10% higher in the HD
group, although, due to the large variability, this still fails
to reach conventional levels of significance. Nevertheless,
it should be realised that this also represents, at the very
least, a preservation of microvascular competence in the
HD group, and that this is associated with a more normal
pattern of fibre type CSA (in terms of relative mean CSA
of different fibre types) and better oxidative potential
as reflected in the measure of cytochrome c oxidase.
Consistent with this general picture of better preserved
morphometric indices of muscle function in the HD
patients, Figure 2 shows that their individual data points
for CC/F in relation to the fibre CSA all lie above the
regression line for the CAPD patients.
The better-capillarized fibres in the HD patients did
not appear to be the result of different levels of habitual
physical activity or functional capacity. One study [22],
however, suggested that capillary measurements should
be corrected for mean fibre CSA. This does not appear
to be a significant factor affecting the capillary bed in our
present study, since there was no relationship between
CSA and CC/F between the two groups (Figure 2). The
enhanced capillarization might, however, be associated
with the use of heparin in the HD group combined with
lower haemoglobin levels and lower mean venous tCO2
and given similar habitual physical activity levels in both
groups.
RFPs undergoing HD therapy receive about 2000–
6000 IU of heparin three times a week in order to avoid
C© 2004 The Biochemical Society
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blood coagulation when dialysed by an artificial kidney.
Heparin has been suggested as a primary factor involved
in angiogenesis [21]. In 1982, Taylor and Folkman [23]
showed that heparin acts as a positive regulator of
angiogenesis by trapping growth factors near to the cell
surface and then binding to their receptors. However,
heparin and/or heparan sulphate are unable to trigger an-
giogenesis by themselves, but act as a positive modulator
(enhancer or amplifier) of angiogenic processes triggered
by other stimuli, such hypoxia and exercise [24]. Fujita
et al. [24] showed that heparin treatment alone without
exercise did not improve myocardial ischaemia, whereas
heparin administration combined with exercise did result
in improvements.
It is conceivable, therefore, to assume that the increased
number of capillaries (CC/F) in the muscle of the HD
group could be a consequence of the angiogenic and
growth effect of heparin administration, in combination
with mild anaemia and acidosis, in the presence of similar
levels of daily physical activity.
In conclusion, we have found that patients on HD
therapy have enhanced capillarization, increased activity
of cytochrome c oxidase and a trend for larger muscle
CSA of the locomotorymuscles comparedwith the RFPs
counterparts receiving CAPD therapy. Future studies
involving this population should take into account that
patients receiving different dialysis treatments experience
different muscle characteristics.
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